FY2025 EPS Estimates for Haemonetics Decreased by Analyst
Haemonetics Co. (NYSE:HAE – Free Report) – Research analysts at Zacks Research lowered their FY2025 EPS estimates for shares of Haemonetics in a report released on Thursday, March 13th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings of $4.54 per share for the year, down from their prior […]
